Bcl2l1 is regulated by the lncrna mir4435-2hg-mir-513a-5p-bcl2l1 cerna axis and serves as a biomarker for pancreatic adenocarcinoma treatment and prognosis

HIGHLIGHTS

• What: The results of the analysis showed a significant negative correlation between BCL2L1 and IC50 of gemcitabine, 5-fluorouracil, and paclitaxel (Fig 5A-C). The authors report for the first time that MIR4435-2HG may be involved in the progression of PAAD as well as contribute to the poor prognosis of PAAD patients by promoting BCL2L1 through adsorption of miR-513a-5p.The human immune system constantly checks somatic_cells for oncogene-related molecular alterations and eradicates them before they become cancerou .
• Who: Pancreatic adenocarcinoma and collaborators from the Yangpu Hospital, Tongji University have published the . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.